From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 526,999 shares, representing 3.08% for $7.52 million under the buyback announced on March 14, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.57 USD | -1.49% |
|
-3.91% | -26.14% |
06-05 | Transcript : OptimizeRx Corporation - Shareholder/Analyst Call | |
05-14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.14% | 193M | |
+29.56% | 451B | |
+40.92% | 296B | |
+14.03% | 147B | |
+9.86% | 94.95B | |
+27.89% | 90.69B | |
+69.09% | 63.25B | |
+15.16% | 46.57B | |
+14.74% | 34.97B | |
-15.39% | 30.2B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023.